BeOne Medicines (BEIGF) Income from Non-Controlling Interests (2017 - 2020)
Historic Income from Non-Controlling Interests for BeOne Medicines (BEIGF) over the last 4 years, with Q4 2020 value amounting to $96000.0.
- BeOne Medicines' Income from Non-Controlling Interests fell 4216.87% to $96000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $96000.0, marking a year-over-year increase of 10270.65%. This contributed to the annual value of -$3.6 million for FY2020, which is 8548.72% down from last year.
- BeOne Medicines' Income from Non-Controlling Interests amounted to $96000.0 in Q4 2020, which was down 4216.87% from -$1.4 million recorded in Q3 2020.
- BeOne Medicines' Income from Non-Controlling Interests' 5-year high stood at $1.5 million during Q4 2018, with a 5-year trough of -$1.4 million in Q3 2020.
- Over the past 4 years, BeOne Medicines' median Income from Non-Controlling Interests value was -$429000.0 (recorded in 2019), while the average stood at -$401666.7.
- Within the past 5 years, the most significant YoY rise in BeOne Medicines' Income from Non-Controlling Interests was 349302.33% (2018), while the steepest drop was 51333.33% (2018).
- Quarter analysis of 4 years shows BeOne Medicines' Income from Non-Controlling Interests stood at $43000.0 in 2017, then skyrocketed by 3493.02% to $1.5 million in 2018, then plummeted by 89.26% to $166000.0 in 2019, then tumbled by 42.17% to $96000.0 in 2020.
- Its Income from Non-Controlling Interests was $96000.0 in Q4 2020, compared to -$1.4 million in Q3 2020 and -$1.1 million in Q2 2020.